Evidence map›Paper›PMID 31878018›Full record

ReviewMicromachines2019

Vascularized Microfluidics and the Blood-Endothelium Interface.

Christopher A Hesh, Yongzhi Qiu, Wilbur A Lam

Abstract readReview
In one paragraph

Review in Micromachines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Model Systems to Study the Mechanism of Vascular Aging.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Organ-on-a-chip systems for vascular biology.Journal of molecular and cellular cardiology · 2021
    Review
  15. Review
  16. Studying the Endothelial GlycocalyxFrontiers in cardiovascular medicine · 2021
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher A HeshDepartment of Radiology & Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0003-2559-7758
Yongzhi QiuWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
Wilbur A LamWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.

Funding

Engineering biophysical microtechnologies for hematologic applications in health and diseaseR35HL145000 · NHLBI · EMORY UNIVERSITY · PI LAM, WILBUR A · 2019 to 2025
$5.0M
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic TechnologiesR01HL140589 · NHLBI · EMORY UNIVERSITY · PI LAM, WILBUR A, WOOD, DAVID KEVIN · 2018 to 2021
$3.0M
Platelet-like particles for augmenting hemostasisR01HL130918 · NHLBI · UNIVERSITY OF VIRGINIA · PI BARKER, THOMAS HARRISON, LAM, WILBUR A · 2016 to 2019
$2.7M
Modeling atypical hemolytic uremic syndrome with hydrogel-based microvasculature-on-chip technologiesR21EB028519 · NIBIB · EMORY UNIVERSITY · PI CHONAT, SATHEESH, QIU, YONGZHI · 2019 to 2021
$639k
Leveraging microfluidic technologies and cell-scale simulations to investigate sickle cell vasculopathyR21MD011590 · NIMHD · EMORY UNIVERSITY · PI GRAHAM, MICHAEL D., LAM, WILBUR A · 2018 to 2019
$439k
NHLBI NIH HHS R35 HL145000NIH HHS R01 HL130918NIH HHS R01 HL140589NIH HHS R21 EB028519NIH HHS R21 MD011590NIH HHS R35 HL145000
6 · The paper itself

Abstract

The microvasculature is the primary conduit through which the human body transmits oxygen, nutrients, and other biological information to its peripheral tissues. It does this through bidirectional communication between the blood, consisting of plasma and non-adherent cells, and the microvascular endothelium. Current understanding of this blood-endothelium interface has been predominantly derived from a combination of reductionist two-dimensional in vitro models and biologically complex in vivo animal models, both of which recapitulate the human microvasculature to varying but limited degrees. In an effort to address these limitations, vascularized microfluidics have become a platform of increasing importance as a consequence of their ability to isolate biologically complex phenomena while also recapitulating biochemical and biophysical behaviors known to be important to the function of the blood-endothelium interface. In this review, we discuss the basic principles of vascularized microfluidic fabrication, the contribution this platform has made to our understanding of the blood-endothelium interface in both homeostasis and disease, the limitations and challenges of these vascularized microfluidics for studying this interface, and how these inform future directions.

Indexed as

blood vesselendotheliumlab-on-chipmicrofluidicsmicrovasculature

Identifiers

PMID31878018
PMCPMC7019435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.